Romania Biomaterials in Healthcare Market Analysis Report [2022-30] I Insights10

Romania Biomaterials in Healthcare Market Analysis

$ 3999

The Romania Biomaterials in Healthcare Market is expected to witness growth from $453 Mn in 2022 to $1244 Mn in 2030 with a CAGR of 13.45% for the forecasted year 2022-2030. In Romania, the demand for biomaterials like bone transplants, tissue scaffolds, and implantable devices is increasing as Romania's healthcare sector expands. The population is aging, chronic diseases are on the rise, and there are more and more medical treatments that use biomaterials as a result. The market is segmented by type and by application. Some key players in this market include: Adar Unic Solutions SRL.

ID: IN10ROMD003 CATEGORY: Medical Devices GEOGRAPHY: Romania

Buy Now

Romania Biomaterials in Healthcare Market Executive Analysis

The Romania Biomaterials in Healthcare Market size is at around $453 Mn in 2022 and is projected to reach $1244 Mn in 2030, exhibiting a CAGR of 13.45% during the forecast period. In 2022, Romania's current health spending account for 6.3% of GDP. Only $870 per person, or less than one-third of the EU average, spent on healthcare in Romania in 2015, the member country with the lowest expenditures. The EU average of 9.9% is considerably higher than the lowest health-related GDP share of 6.3%, which is also the lowest.

In Romania, in order to replace or repair injured human bodily tissues, biomaterials are contaminants that are used in tissue engineering, implants, and medical equipment. They are a quickly growing area with many applications in Romanian healthcare. Biomaterials are used to create implants that replace missing or damaged bodily parts, including hip or knee joints, pacemakers, and dental implants. Biomaterials can be used to create scaffolds or matrices that support the development of new tissues, like bone or cartilage, in people with injuries or degenerative illnesses. Biomaterials can be used to create drug delivery systems that transport medications to specific body parts at a controlled rate. Biomaterials can be used to create dressings and other wound care supplies to speed up recovery and prevent infection. Biomaterials are designed to be inert with human tissues, which reduces the risk of rejection and hastens healing. Biomaterials are designed to last a very long period and are therefore replaced less often. Because they can be customized to meet the specific requirements of each patient, biomaterials offer individualized treatment options. Biomaterials can shorten the duration of the rehabilitation process by promoting faster healing and reducing the likelihood of complications. Biomaterials can enhance human life by providing treatments for illnesses that were previously incurable.

romania biomaterials in healthcare market

Market Dynamics

Market Growth Drivers

In Romania, the demand for biomaterials like bone transplants, tissue scaffolds, and implantable devices is increasing as Romania's healthcare sector expands. The population is aging, chronic diseases are on the rise, and there are more and more medical treatments that use biomaterials as a result. The building of new hospitals and medical facilities is just one example of the significant investments the Romanian government has made in the country's healthcare infrastructure. As the market for implants and medical devices continues to expand, this investment is anticipated to open up new opportunities for biomaterials makers in Romania healthcare market. Another force behind the expansion of the Romanian healthcare industry is the creation of novel and enhanced biomaterials. Manufacturers are always looking into new materials and technologies to better the performance of their goods and the results for patients. The Romanian government has put in place measures, such as tax breaks and streamlined regulatory procedures, to promote investment in the healthcare industry. Due to the stringent regulatory oversight required to ensure the safety and efficacy of biomaterials, this has created a favourable environment for their makers.

Market Restraints

In Romania, the cost of producing biomaterials is frequently high, and this expense may be passed on to the consumer. The high expense of biomaterials can be a deterrent to adoption in a price-sensitive market like Romania, especially for patients who are footing the bill for their own healthcare. In Romania, biomaterials are still a comparatively new technology, and patients and healthcare professionals are not sufficiently informed about the advantages of these products. Low acceptance rates and gradual market expansion may result from this.

Competitive Landscape

Key Players

Italtrade & Co S.R.L. (RO)
Adar Unic Solutions SRL (RO)
BASF SE
Johnson and Johnson
Medtronic
Evonik Industries

Recent Notable Deals

2022: For the purpose of distributing its products in the Romanian market, BioLucid entered into a partnership arrangement with the OrthoSera company in Romania. The goal of this collaboration was to make BioLucid's regenerative medicine items and biomaterials more accessible to patients and medical professionals in Romania.

Healthcare Policies and Regulatory Landscape

The National Agency for Medicines and Medical Devices (ANMDM) is one of the primary governing organizations in Romania's healthcare system. The regulation of biomaterial effectiveness, safety, and quality falls under the purview of ANMDM. Before being sold in Romania, all medical devices, including biomaterials, must be registered with ANMDM. Manufacturers must provide comprehensive information about the device's intended use, make-up, and clinical efficacy in order for it to be registered. In addition to ANMDM, a number of business groups and professional associations also contribute to the development of Romania's healthcare laws and regulations. These organizations include the Romanian Dental Association (ADR), the Romanian Society of Biomaterials (RSB), and the Romanian Association of Medical Devices Manufacturers and Distributors (ARORMED).

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Biomaterials in Healthcare Market Segmentation

By Type (Revenue, USD Billion):

Based on type, the market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials. The Metallic Biomaterials segment accounted for the largest share of the Romania market in 2019. The growing geriatric population Romanialy is expected to drive growth for this segment.

Metallic Biomaterials
- Stainless Steel
- Titanium & Titanium Alloys
- Cobalt-Chrome Alloys
- Gold
- Silver
- Magnesium
Polymeric Biomaterials
- Polymethylmethacrylate
- Polyethylene
- Polyester
- Silicone Rubber
- Nylon
- Polyetheretherketone
- Other Polymeric Biomaterials
Ceramics
- Calcium Phosphate
- Zirconia
- Aluminum Oxide
- Calcium Sulfate
- Carbon
- Glass
Natural Biomaterials
- Hyaluronic Acid
- Collagen
- Gelatin
- Fibrin
- Cellulose
- Chitin
- Alginates
- Silk

By Application (Revenue, USD Billion):

The cardiovascular, orthopaedic, dental, plastic surgery, wound healing, tissue engineering, ophthalmology, neurological/CNS, and other applications segments are made up of the biomaterials market. The market category for wound healing is anticipated to have the highest CAGR in 2019. The market will increase as a result of factors including expanding healthcare infrastructure, a large population pool, a rising diabetic population, and rising healthcare spending. Surgical Guides

Cardiovascular
- Catheters
- Stents
- Implantable Cardiac Defibrillators
- Pacemakers
- Sensors
- Heart Valves
- Vascular Grafts
- Guidewires
- Others
Orthopedic
- Joint Replacement
  - Knee Replacement
  - Hip Replacement
  - Shoulder Replacement
  - Others
- Viscosupplementation
- Bioresorbable Tissue Fixation
- Spine?
  - Spinal Fusion Surgeries
  - Minimally Invasive Fusion Surgeries
  - Motion Preservation & Dynamic Stabilization Surgeries
    - Pedicle-Based Rod Systems
    - Interspinous Spacers
    - Artificial Discs
- Fracture Fixation Devices
  - Bone Plates
  - Screws
  - Pins
  - Rods
  - Wires
- Synthetics Bone Grafts
Ophthalmology
- Contact Lenses
  - Intraocular Lenses
  - Functional Replacement of Ocular Tissues
  - Synthetic Corneas
  - Others
Dental
- Dental Implants
- Dental Bone Grafts & Substitutes
- Dental Membranes
- Tissue Regeneration
Plastic Surgery
- Soft-Tissue Fillers
- Craniofacial Surgery
Wound Healing
- Wound Closure Devices
  - Sutures
  - Staples
- Surgical Hemostats
- Internal Tissue Sealants
- Adhesion Barriers
- Hernia Meshes
Tissue Engineering
- Scaffolds for Regenerative Medicine
- Nanomaterials for Biosensing
- Tailoring of Inorganic Nanoparticles
  ?
Neurological/Central Nervous System Applications
- Shunting Systems
- Cortical Neural Prosthetics
- Hydrogel Scaffolds for CNS Repair
- Neural Stem Cell Encapsulation
  ?
Other Applications
- Drug Delivery Systems
- Gastrointestinal Applications
- Bariatric Surgery
- Urinary Applications

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.